Clinical Research

Clinical Research Programs

We are excited to offer patients ongoing access to new therapies to treat bone, joint and muscle conditions such as arthritis, osteoporosis, and autoimmune diseases through our on-site Clinical Research Center. This unique feature of our clinic plays a significant role in our outstanding abilities to provide our patients a comprehensive diagnosis and individualized care.

Our Research Director, board certified rheumatologist Dr. Richard Jimenez works closely with a full-time staff researching the latest medical breakthroughs and clinical trials available to rheumatology patients. The efforts of this dedicated team ensure that our patients are educated about the most recent medical findings, research studies and new patient therapies. Learn more about current research opportunities.

If you have RA, you can help doctors evaluate an investigational medication that is taken in addition to your current RA treatment.

As your Rheumatoid arthritis has progressed, it’s not as easy to complete your everyday activities. Your joint stiffness, pain, and swelling has increased and changed the way you live.

For patients like you, researchers are currently conducting a clinical trial to evaluate an investigational RA treatment. They want to learn more about etanercept, an approved medication for the treatment of RA, when it is used in combination with your current RA therapy. Under the marketed name Enbrel, etanercept has been approved by the United States Food and Drug Administration and Health Canada for the treatment of moderately to severely active RA.

If you have been diagnosed with moderaltely active RA, we hope that you will consider participating in this trial.

To pre-qualify for this trial, you must be:

  • Between 18 and 80 years of age
  • Medically diagnosed with rheumatoid arthritis for at least six months
  • Currently taking an approved disease modifying anti-rheumatic drug (DMARD) consecutively for at least 12 weeks (the trial staff will provide you with a complete list of approved DMARDs)

All trial-related visits, tests, and treatments that are not standard of care will be provided to participants at no cost. In addition, reimbursement for travel may also be provided.

To learn more, please call 206-368-6135.

Research Opportunities


Questions regarding research can be directed to:
Laura Vinson
(206) 368.6123